BSE filing, NSE: LINKPH. Summary written from the filing by ALFA Finder's alert engine.
Link Pharma Chem Ltd: key numbers
- Share price
- ₹24.05
- Market cap
- ₹10.68 Cr
- Revenue (annual)
- ₹27.43 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- -1642.8×Sector 33.6×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Link Pharma Chem Ltd
All →Link Pharma Chem Other Announcement
Link Pharma Chem Ltd filed a periodic non-applicability notice for Reg 23(9) RPT disclosure. The company's paid-up capital and net worth fall below LODR thresholds, so no disclosure is required.
Link Pharma Chem Q2 FY27 Results: Net Loss of ₹0.2 Cr
Link Pharma Chem approved unaudited results for the quarter and half year ended 30 September 2026. Revenue was Rs.533.13 Lakh with a loss of Rs.22.31 Lakh for the quarter.
- Key figure
- Net loss ₹0.2 Cr
Link Pharma Chem Board Meeting Date
Link Pharma Chem's board meets on 3 November 2026 to approve unaudited half-year results. The trading window stays closed until results are declared.
Link Pharma Chem Other Announcement
Link Pharma Chem Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure provides the updated ownership structure for the company.
Link Pharma Chem Legal & Regulatory
Link Pharma Chem Ltd received a GST order reducing the total demand and penalty for FY 2021-22. The company plans to appeal the decision.
- Value
- ₹0.18 Cr
Link Pharma Chem Management Change
Link Pharma Chem Limited has announced the re-appointment of Rishikesh Thakur and Satish G Thakur as Executive Directors for a term of 36 months each.
Other board meeting date announcements
All →Bai-Kakaji Polymers Board Meeting Date
Bai-Kakaji Polymers will meet on November 6, 2026 to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The filing is an advance board meeting intimation with no figures disclosed yet.
Shriram Properties Board Meeting Date
Shriram Properties Limited intimated a board meeting on 13 Nov 2026 to consider unaudited standalone and consolidated quarterly financial results for the period ended September 2026. Trading window closes 01 Oct to 15 Nov 2026.
Rubfila International Board Meeting Date
Rubfila International has scheduled a board meeting on November 12, 2026 to approve unaudited quarterly results for the quarter ended September 30, 2026. The trading window stays closed until 48 hours after the meeting.
New Markets Avenue Board Meeting Date
New Markets Avenue schedules a board meeting on 6 November 2026 to consider September quarter results. Trading window stays closed until 48 hours after results.
Remsons Industries Board Meeting Date
Remsons Industries will hold a board meeting on 7 November 2026 to approve results. Trading window stays closed until 9 November 2026.
Dollar Industries Board Meeting Date
Dollar Industries will hold a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. The filing is a prior intimation with no amount stated.